3610 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

Dated: January 15, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–01114 Filed 1–22–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Statement of Organization, Functions 

and Delegations of Authority 

This notice amends Part R of the 

Statement of Organization, Functions 

and Delegations of Authority of the 

Department of Health and Human 

Services (HHS), Health Resources and 

Services Administration (HRSA) (60 FR 

56605, as amended November 6, 1995; 

as last amended at 79 FR 75164–75165 

dated December 17, 2014). 

This notice reflects organizational 

changes in the Health Resources and 

Services Administration (HRSA), 

Healthcare Systems Bureau (HSB). 

Specifically, this notice: (1) Updates the 

functional statement for the Division of 

National Hansen’s Disease Programs 

(RRH). 

Chapter RR—Healthcare Systems 

Bureau 

Section RR—00, Mission 

The Healthcare Systems Bureau (HSB) 

protects the public health and improves 

the health of individuals through an 

array of programs that provide national 

leadership and direction in targeted 

areas. 

Section RR–20, Functions 

Delete the functional statement for the 

Division of National Hansen’s Disease 

Programs (RRH) in its entirety and 

replace with the following: 

Division of National Hansen’s Disease 

Programs (RRH) 

The National Hansen’s Disease 

Programs (NHDP) in accordance with 

regulations of the Public Health Service 

(PHS) Act, Sec. 320 as amended by Sec. 

211, PL105–78); (1) provides care and 

treatment for persons with Hansen’s 

Disease (leprosy), including managing a 

national short-term and outpatient 

health care delivery program providing 

specialized services to persons with 

Hansen’s Disease; (2) conducts and 

promotes the coordination of research 

(including clinical research), 

investigations, demonstrations, and 

studies relating to the causes, diagnosis, 

treatment, control, and prevention of 

Hansen’s disease and other 

mycobacterial diseases and 

complications related to such diseases; 

(3) conducts training in the diagnosis 

and management of Hansen’s disease 

and related complications; (4) provides 

education and training to staff from the 

outpatient Hansen’s Disease Clinics and 

private physicians; (5) operates and 

oversees the National Hansen’s Disease 

Museum and Cemetery; (6) consults on 

the coordination of activities within 

HRSA and HHS, and with other federal 

agencies, state and local governments, 

and other public and private 

organizations involved in Hansen’s 

Disease activities; and (7) manages a 

network of outpatient clinics through 

contracts providing care to persons with 

Hansen’s Disease. 

Section RR–30, Delegations of Authority 

All delegations of authority and redelegations of authority made to HRSA 

officials that were in effect immediately 

prior to this reorganization, and that are 

consistent with this reorganization, 

shall continue in effect pending further 

re-delegation. 

This reorganization is effective upon 

date of signature. 

Dated: January 16, 2015. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2015–01131 Filed 1–22–15; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Application (P01). 

Date: February 19, 2015. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Eleazar Cohen, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health, NIAID, 5601 

Fishers Lane, Rockville, MD 20892, 240–669– 

5881, ec17w@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01). 

Date: February 23, 2015. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Room 

3F100, 5601 Fishers Lane, Rockville, MD 

20892 (Telephone Conference Call). 

Contact Person: Quirijn Vos, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

DHHS/NIH/NIAID, 5601 Fishers Lane, 

Rockville, MD 20892, 240–669–5059, qvos@

niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01). 

Date: February 26, 2015. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Eleazar Cohen, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health, NIAID, 5601 

Fishers Lane, Rockville, MD 20892, 240–669– 

5881, ec17w@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 16, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–01087 Filed 1–22–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 


tkelley on DSK3SPTVN1PROD with NOTICES